` ABC (Abcam PLC) vs FTSE All Share Index Comparison - Alpha Spread

ABC
vs
F
FTSE All Share Index

Over the past 12 months, ABC has underperformed FTSE All Share Index, delivering a return of 0% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
ABC vs FTSE All Share Index

Loading
ABC
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ABC vs FTSE All Share Index

Performance Gap Between ABC and ASX
HIDDEN
Show

Performance By Year
ABC vs FTSE All Share Index

Loading
ABC
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Abcam PLC vs Peers

FTSE All Share Index
ABC
RYI
AVGR
BROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Abcam PLC
Glance View

Market Cap
2.8B GBX
Industry
Biotechnology

In the bustling realm of the life sciences, Abcam PLC has carved out a distinct niche as a leading provider of research tools and reagents that are fundamental to scientific discovery and innovation. Born in the vibrant academic environment of Cambridge, England, Abcam was founded in 1998 by Jonathan Milner and a small group of fellow scientists frustrated by the lack of quality and reliability in antibody products. The company’s vision was to fuel research globally by providing a reliable source of quality antibodies, knocking down barriers faced by researchers. From this germ of an idea grew Abcam’s expansive catalog, housing an impressive array of antibodies, proteins, reagents, and assays. These tools have become essential in the pursuit of breakthroughs in fields such as cancer research, drug development, and diagnostics. Abcam thrives on a business model that combines product innovation with an e-commerce platform that connects it to a global customer base of researchers and institutions. By meticulously validating the performance of their products, the company ensures that researchers can rely on the tools to deliver precise and reproducible results. This commitment to quality has fostered a level of trust that underpins the company’s growth. Abcam's revenues primarily stem from sales of its proprietary products alongside a curated selection from third-party vendors. The firm also invests significantly in understanding the evolving needs of the scientific community, tailoring its offerings to support cutting-edge research. This client-centric approach, coupled with their robust online presence, has facilitated Abcam’s expansion far beyond its roots, transforming it into a key player that supports scientific advancement globally.

ABC Intrinsic Value
Not Available
Back to Top